CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...

The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws LOS ANGELES--(BUSINESS WIRE)--Researchers at ...

A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...

For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians. Now, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have combined ...

The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...

A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...

A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...

The field of cancer immunology has experienced remarkable advancements in diagnostic capabilities, largely due to the integration of multispectral and hyperspectral imaging technologies. These imaging ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...